WuXi Biologics (Cayman) Inc. (BKK:WUXI06)
Thailand
· Delayed Price · Currency is THB 3.380
+0.200 (6.29%)
At close: Dec 4, 2025
WuXi Biologics Revenue
WuXi Biologics had revenue of 9.95B CNY in the half year ending June 30, 2025, with 17.21% growth. This brings the company's revenue in the last twelve months to 20.05B, up 17.16% year-over-year. In the year 2024, WuXi Biologics had annual revenue of 18.68B with 9.63% growth.
Revenue (ttm)
20.05B CNY
Revenue Growth
+17.16%
P/S Ratio
6.05
Revenue / Employee
1.59M CNY
Employees
12,575
Market Cap
550.14B THB
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.68B | 1.64B | 9.63% |
| Dec 31, 2023 | 17.03B | 1.77B | 11.56% |
| Dec 31, 2022 | 15.27B | 4.98B | 48.38% |
| Dec 31, 2021 | 10.29B | 4.68B | 83.35% |
| Dec 31, 2020 | 5.61B | 1.63B | 40.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Delta Electronics (Thailand) PCL | 182.19B |
| Advanced Info Service PCL | 223.45B |
| PTT PCL | 2,748.04B |
| Airports of Thailand PCL | 66.68B |
| Gulf Development PCL | 94.80B |
| Kasikornbank PCL | 153.07B |
| SCB X PCL | 133.85B |
| PTT Exploration and Production PCL | 279.96B |